StonvexLoading…
StonvexStonvexStonvexCore line items from CYPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2021 2021-12-31 | Q3 2021 2021-09-30 | Q2 2021 2021-06-30 | Q1 2021 2021-03-31 |
|---|---|---|---|---|
Revenue | $1.50M | $1.13M | $750.00K | $375.00K |
Operating Income | $-41.43M | $-30.94M | $-18.80M | $-9.17M |
Net Income | $-40.59M | $-29.80M | $-18.66M | $-9.13M |
EPS (Diluted) | $-0.47 | $-0.39 | $-0.24 | $-0.12 |
Total Assets | $117.91M | $128.08M | $37.94M | $45.81M |
Total Liabilities | $10.02M | $11.26M | $8.06M | $7.43M |
Cash & Equivalents | $114.92M | $124.77M | $35.73M | $43.49M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 59.66M | 87.84M | 59.67M | 59.67M |